Reza Zadno's Net Worth

$19.3 Million

Estimate Recalculated Nov 8, 2024 04:39PM EST

Who is Reza Zadno?

Reza Zadno has an estimated net worth of $19.3 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, Invuity, Inc., PROCEPT BioRobotics Corp, and Carbylan Therapeutics, Inc..

SEC CIK

Reza Zadno's CIK is 0001632326

Past Insider Trading and Trends

2019 was Reza Zadno's most active year for acquiring shares with 8 total transactions. Reza Zadno's most active month to acquire stocks was the month of February. 2019 was Reza Zadno's most active year for disposing of shares, totalling 12 transactions. Reza Zadno's most active month to dispose stocks was the month of October. 2022 saw Reza Zadno paying a total of $1,154,986.56 for 118,896 shares, this is the most they've acquired in one year. In 2024 Reza Zadno cashed out on 38,054 shares for a total of $691,626.46, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.38K
—
—
0
Nov 21
Form 4
+56.18%
6.5K
$22.93
-$40,196.29
18.06K
Mar 1 - Sep 3
Form 4/A
∞
11.56K
—
—
11.56K
Feb 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Feb 19
Form 4
∞
16.82K
—
—
16.82K
Feb 13
Form 3
—
0
—
—
0
No matching records found

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-31.25%
-4.00K
$9.16
-$36,652.80
8.8K
May 3
Form 4
∞
12.8K
—
—
12.8K
Jun 19
Form 4/A
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
No matching records found

PROCEPT BioRobotics Corp (PRCT) Snapshot price: $76.6

President, CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$47.69
-$24,989,376.43
258.44K
Oct 30
Form 4
+9.99%
23.48K
$4.37
$102,625.08
258.44K
Jul 31
Form 4/A
+24.17%
48.58K
—
—
249.53K
Mar 6
Form 4
-2.19%
-5.39K
$48.83
-$263,242.53
241.32K
Mar 18
Form 4
+22.77%
45.75K
$46.67
-$428,383.93
246.71K
Mar 6
Form 4
+2.63%
5.15K
$4.37
$22,496.76
200.96K
Oct 18
Form 4
+11.37%
20K
$4.37
$87,378.15
195.81K
Apr 28
Form 4
+12.85%
20.02K
$4.37
$87,496.14
175.81K
Apr 4
Form 4
-3.31%
-5.33K
$31.84
-$169,866.40
155.79K
Mar 16
Form 4
+69.01%
65.79K
—
—
161.13K
Feb 16
Form 4
+70.17%
39.31K
$29.38
$1,154,986.56
95.34K
Mar 31
Form 4
+6.45%
3.39K
—
—
56.02K
Sep 17
Form 3
—
0
—
—
0
No matching records found

Carbylan Therapeutics, Inc. (KALV) Snapshot price: $12.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 3
Form 4
—
0
—
—
0
Apr 24
Form 3
—
0
—
—
0
No matching records found